Global Sanger Sequencing Service Market Strategic Research Report

Scope of the Report

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

Global Sanger Sequencing Service key players include Thermo Fisher, Eurofins Scientific, and Azenta. The top three producers together hold over 40% of the market share, with Thermo Fisher being the largest producer with 16%. In terms of product categories, PCR products have the largest market share with 44%, followed by plasmid DNA, and in terms of applications, research institutions are the top application area with 28% market share, while biotech companies and universities are also important applications.

This report presents a comprehensive overview of the global Sanger Sequencing Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• PCR Products
• Plasmid DNA
• Bacterial Artificial Chromosomes (BAC)
• Others

Segment by players, this report covers

• Thermo Fisher
• Azenta
• Eurofins Scientific
• LGC Biosearch Technologies
• Fasteris
• QuintaraBio
• Laragen
• Microsynth
• Nucleics
• GenScript Biotech
• CeMIA
• StarSEQ
• Source BioScience
• Guangzhou Life Technologies DaAn
• SciGenom Labs
• Psomagen
• Tsingke Biotechnology
• GenHunter
• CD Genomics
• Shanghai Personalbio Technology
• Suzhou Hongxun Biotechnologies
• Guangzhou IGE Biotechnology

Segment by Application

• Research Institutions
• Biotech Companies
• Universities and Colleges
• Hospitals and Clinics
• Pharmaceutical Companies
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Sanger Sequencing Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Research Institutions, Biotech Companies, Universities and Colleges evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact